Special Report: Summary of the eighth workshop of the worldwide network for blood and marrow transplantation on the status and issues related to hematopoietic stem cell transplantation in near-east countries, held in Pakistan from September 22 to 23, 2022.

Autor:	Greinix HT; Division of Hematology, Medical University Graz, Graz, Austria., Iftikhar R; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan., Chaudhry QUN; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan., Ahmed P; Quaid-e-Azam International Hospital, Islamabad, Pakistan., Al-Khabori M; Hematology Department, Sultan Qaboos University Hospital, Muscat, Oman., Gaziev J; Hematology Department, National Center for Cancer Care & Research, Hamad Medical Corporation, Doha, Qatar., Hamidieh AA; Tehran University of Medical Sciences, Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran, Iran., Hashmi S; Department of Medicine, Khalifa University, SSMC, Abu Dhabi, United Arab Emirates.; College of Medical and Health Sciences, Abu Dhabi, United Arab Emirates., Khan M; BMT Unit, Department of Hematology, Dhaka Medical College Hospital, Dhaka, Bangladesh., Poudyal BS; Civil Service Hospital, Hematology and Bone Marrow Transplant Services, Kathmandu, Nepal., Shaheen M; King Faisal Specialist Hospital and Research Centre, Department of Hematology, SCT and Cellular Therapy, Riyadh, Saudi Arabia., Rasheed W; King Faisal Specialist Hospital and Research Centre, Oncology Center, Riyadh, Saudi Arabia., Galeano S; Hospital Británico, Montevideo, Uruguay., Kodera Y; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan., Niederwieser D; Division of Hematology and Medical Oncology, University of Leipzig, Leipzig, Germany., Ahmed SO; King Faisal Specialist Hospital and Research Center, Oncology Center Riyadh, Riyadh, Saudi Arabia., Atsuta Y; Aichi Medical University School of Medicin, Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi, Japan., Baldomero H; University Hospital Basel, the Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, Basel, Switzerland., Frutos C; Central Hospital of the Instituto de Prevision Social, Instituto Nacional de Ablacion y Trasplantes, Department of Hematology, Asuncion, Paraguay., Iida M; Aichi Medical University School of Medicine, Department of Promotion for Blood and Marrow Transplantation, Nagakute, Japan., Okamoto S; Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Rondelli D; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL, USA., Schwartz J; Moffitt Cancer Center, Transfusion Services, Tampa, FL, USA., Seber A; Department of Medicine, Universidade Federal de Sao Paulo Escola Paulista de Medicina, Sao Paulo, Brazil., Weisdorf D; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA., Worel N; Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Vienna, Austria., Chatzixiros E; Department of Health Products Policies and Standards, WHO Headquarters, Geneva, Switzerland., Koh MB; University of London, Institute for Infection and Immunity, St. George's, London, United Kingdom., Aljurf M; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Saudi Arabia.
Jazyk:	angličtina
Zdroj:	Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2024 Jul-Sep 01; Vol. 17 (3), pp. 190-199. Date of Electronic Publication: 2024 Oct 04.
DOI:	10.4103/hemoncstem.HEMONCSTEM-D-24-00011
Abstrakt:	The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell transplant (HSCT) activity in the World Health Organization (WHO) Eastern Mediterranean Region (EMRO). Participating countries, including Pakistan, Oman, Iran, and Saudi Arabia, reported increased HSCT in the last few years, whereas others from the EMRO and beyond, including Qatar, United Arab Emirates, Nepal, and Bangladesh, started HSCT recently and have developed HSCT programs with excellent results. During educational sessions and open dialog, participating teams and international experts from the WBMT shared their experience and discussed minimum essential requirements for establishing and expanding HSCT in emerging countries, indications for HSCT training and dissemination of knowledge, stem cell donor selection and safety, quality assurance in transplant centers, and the value and importance of transplant outcome databases. International support, collaboration, and local engagement, including government participation and WHO assistance, are valuable in increasing HSCT access worldwide. (Copyright © 2024 Hematology/Oncology and Stem Cell Therapy.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu